Healthy volunteers sought for early drug safety check

NCT ID NCT07090785

Recruiting now Knowledge-focused Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a new drug called LY4088044 in healthy adults to see if it is safe and how the body handles it. About 104 participants will receive the drug or a placebo, either as a shot under the skin or into a vein. The study lasts up to 92 weeks and focuses on side effects and how the drug moves through the body. It does not aim to treat any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Collaborative Neuroscience Network - CNS
RECRUITING

Los Alamitos, California, 90720, United States

Contact Phone: •••-•••-••••

Contact
ICON
NOT_YET_RECRUITING

Lenexa, Kansas, 66219, United States

Contact Phone: •••-•••-••••

Contact
ICON
RECRUITING

Salt Lake City, Utah, 84124, United States

Contact Phone: •••-•••-••••

Contact
ICON Early Phase Services
RECRUITING

San Antonio, Texas, 78232, United States

Contact Phone: •••-•••-••••

Contact
Lilly Centre for Clinical Pharmacology
RECRUITING

Singapore, 138623, Singapore

Contact Phone: •••-•••-••••

Contact
New Zealand Clinical Research Christchurch
NOT_YET_RECRUITING

Christchurch, 8011, New Zealand

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.